Accessibility Menu
Arrow-Thin-Down
S&P 500
6,704.40
+1.1%
+72.21
Arrow-Thin-Down
DJI
46,957.37
+0.9%
+398.90
Arrow-Thin-Down
NASDAQ
22,406.10
+1.4%
+300.74
Arrow-Thin-Down
Bitcoin
$73,868.00
+3.3%
+$2,344.09
Arrow-Thin-Down
AMZN
$210.06
+1.2%
+$2.39
Arrow-Thin-Down
GOOG
$303.40
+0.6%
+$1.94
Arrow-Thin-Down
META
$625.20
+2.0%
+$12.02
Arrow-Thin-Down
MSFT
$399.00
+0.9%
+$3.45
Arrow-Thin-Down
NVDA
$184.92
+2.6%
+$4.67
Arrow-Thin-Down
TSLA
$397.59
+1.6%
+$6.39
Most Active StocksDaily Stock GainersDaily Stock Losers

Why Hims & Hers Terrifies Big Pharma

Big pharma tried to stop Hims & Hers' Super Bowl ad.

By Travis Hoium – Feb 12, 2025 at 11:51AM EST

Hims & Hers (HIMS 2.67%) launched a Super Bowl ad this week, and everyone from pharmaceutical companies to pharmacists tried to block it. Travis Hoium explains why that's a great sign that the company's disruptive potential is real.

*Stock prices used were end-of-day prices of Feb. 11, 2025. The video was published on Feb. 12, 2025.

Read Next

About the Author

Travis Hoium
Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.
TMFFlushDraw
X@travishoium

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Amazon. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

Hims & Hers Health Stock Quote
Hims & Hers Health
NYSE: HIMS
$24.00
(-3.11%)-$0.77
Amazon Stock Quote
Amazon
NASDAQ: AMZN
$209.92
(+1.08%)+$2.25

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services